13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q3 2016. See the latest, Q3 2026 →

Reported value

$1.13B

+30% on the quarter before

Positions

41

22 new, 12 sold out

Top 10

50.8%

of the value

Est. gain

+$26.5M

on stocks held all quarter

Est. return

+5.6%

on those stocks since Q2 2016

Filed

Nov 14, 2016

On SEC EDGAR ↗

Positions as of Sep 30, 2016, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2016. Striped tiles are options.

17 others19%
Ishares Tr15%
Abbvie Inc7.4%
Freeport-McMoRan4.7%Alibaba4.4%
Abbott Labs4.0%
Merck & Co Inc3.8%
Broadcom Ltd3.1%
Activision Blizzard Inc2.9%
Barrick Gold Corp2.9%
Amazon2.7%
Agnico Eagle Mines Ltd2.5%
Hdfc Bank Ltd2.4%
Everpure2.4%
Eog Res Inc2.3%
Zoetis Inc2.2%
Bank Amer Corp2.2%
Ac Immune Sa2.2%
Meta2.1%Applied Materials2.1%
Post Hldgs Inc2.0%
Workday1.9%Intel1.8%
Wisdomtree Tr1.8%
Priceline Grp Inc1.8%

Largest buys

Since Q2 2016, sized at quarter-end prices.

  1. Ishares Tr~$91.4MAdded, 8.3% → 15.0% of the portfolio+2,441,200 shares
  2. Alibaba~$49.8MNew, 0.0% → 4.4% of the portfolio+470,600 shares
  3. Merck & Co Inc~$42.7MNew, 0.0% → 3.8% of the portfolio+683,800 shares
  4. Broadcom Ltd~$34.8MNew, 0.0% → 3.1% of the portfolio+201,900 shares
  5. Activision Blizzard Inc~$33.2MNew, 0.0% → 2.9% of the portfolio+748,700 shares
  6. Abbott Labs~$28.9MAdded, 1.7% → 4.0% of the portfolio+682,600 shares
  7. Eog Res Inc~$26.1MNew, 0.0% → 2.3% of the portfolio+270,300 shares
  8. Bank Amer Corp~$24.7MNew, 0.0% → 2.2% of the portfolio+1,579,700 shares
  9. Ac Immune Sa~$24.7MNew, 0.0% → 2.2% of the portfolio+1,500,000 shares
  10. Applied Materials~$23.4MNew, 0.0% → 2.1% of the portfolio+777,500 shares

Largest sells

Since Q2 2016, sized at quarter-end prices.

  1. Halliburton Co~$98.6MSold out, 11.3% → 0.0% of the portfolio−2,177,600 shares
  2. Meta~$95.5MCut, 12.2% → 2.1% of the portfolio−744,500 shares
  3. Alcoa~$31.4MSold out, 3.6% → 0.0% of the portfolio−3,390,700 shares
  4. Deere & Co~$29.2MSold out, 3.4% → 0.0% of the portfolio−360,500 shares
  5. Cf Ind'S Hldgs Inc.~$22.4MSold out, 2.6% → 0.0% of the portfolio−930,800 shares
  6. Potash Corp Of Sask Inc.~$19.4MSold out, 2.2% → 0.0% of the portfolio−1,192,000 shares
  7. Whitewave Foods Co~$17.1MSold out, 2.0% → 0.0% of the portfolio−364,000 shares
  8. Ctrip.Com Int'L Ltd.~$16.9MSold out, 1.9% → 0.0% of the portfolio−409,000 shares
  9. Agrium Inc~$16.5MCut, 2.3% → 0.3% of the portfolio−181,526 shares
  10. Ingersoll-Rand Plc~$15.2MSold out, 1.7% → 0.0% of the portfolio−238,500 shares

Holdings

As of Sep 30, 2016; changes in shares since Jun 30, 2016.

Positions, sorted by share of the portfolio
HoldingValue
Ishares TrMSCI EMG MKT ETF · shares +117% · price +9.0%15.0%$169.8M+$6.5M
Abbvie IncCOM · shares 0% · price +1.9%7.4%$83.6M+$1.5M
Freeport-McMoRanCL B · shares +41% · price −2.5%4.7%$53.0M−$972,355
AlibabaSPONSORED ADS · shares New4.4%$49.8M—
Abbott LabsCOM · shares +177% · price +7.6%4.0%$45.2M+$1.1M
Merck & Co IncCOM · shares New3.8%$42.7M—
Broadcom LtdSHS · shares New3.1%$34.8M—
Activision Blizzard IncCOM · shares New2.9%$33.2M—
Barrick Gold CorpCOM · shares 0% · price −17.0%2.9%$32.5M−$6.7M
AmazonCOM · shares +1.1% · price +17.0%2.7%$30.0M+$4.3M
Agnico Eagle Mines LtdCOM · shares +22% · price +1.3%2.5%$28.8M+$296,092
Hdfc Bank LtdADR REPS 3 SHS · shares +63% · price +8.4%2.4%$27.2M+$1.3M
EverpureCL A · shares 0% · price +24.3%2.4%$26.9M+$5.3M
Eog Res IncCOM · shares New2.3%$26.1M—
Zoetis IncCL A · shares 0% · price +9.6%2.2%$24.9M+$2.2M
Bank Amer CorpCOM · shares New2.2%$24.7M—
Ac Immune SaSHS · shares New2.2%$24.7M—
MetaCL A · shares −80% · price +12.2%2.1%$24.1M+$2.6M
Applied MaterialsCOM · shares New2.1%$23.4M—
Post Hldgs IncCOM · shares 0% · price −6.7%2.0%$22.5M−$1.6M
WorkdayCL A · shares New1.9%$22.0M—
IntelCOM · shares New1.8%$20.7M—
Wisdomtree TrINDIA ERNGS FD · shares New1.8%$20.6M—
Priceline Grp IncCOM NEW · shares New1.8%$20.3M—
AlphabetCAP STK CL A · shares New1.8%$20.1M—
Total 41 positions100%$1.13B+$26.5M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2016 to Q3 2016: 19 stocks held throughout, up $26.5M (+5.6%).

  1. Ishares Tr+$6.5M+9%
  2. Everpure+$5.3M+24%
  3. Nvidia+$4.8M+46%
  4. Amazon+$4.3M+17%
  5. Meta+$2.6M+12%
  6. Freeport-McMoRan−$972,355−3%
  7. Post Hldgs Inc−$1.6M−7%
  8. Barrick Gold Corp−$6.7M−17%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free